We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Considering that so much of a CEO’s pay is pegged to performance, Celgene CEO Mark Alles doesn't seem a likely candidate for a raise in 2018—not after the company stumbled repeatedly last year.